(Q37304729)

19 August 2017

1 reference

title

Subcutaneous and sublingual immunotherapy in children: complete update on controversies, dosing, and efficacy (English)

1 reference

Désirée E. Larenas-Linnemann

19 August 2017

1 reference

series ordinal

1

object named as

Désirée Larenas-Linnemann

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Current Allergy and Asthma Reports

19 August 2017

published in

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

465-474

1 reference

Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations

19 August 2017

cites work

1 reference

12 December 2020

Significant decrease of IgE antibodies after a three-year controlled study of specific immunotherapy to pollen allergens in children with allergic asthma

1 reference

12 December 2020

Long-term efficacy of preseasonal grass pollen immunotherapy in children.

1 reference

12 December 2020

Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy

1 reference

12 December 2020

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis

1 reference

12 December 2020

Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children

1 reference

12 December 2020

Mechanisms of allergen-specific immunotherapy

1 reference

12 December 2020

Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.

1 reference

12 December 2020

Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study

1 reference

12 December 2020

A controlled trial of immunotherapy for asthma in allergic children

1 reference

12 December 2020

Double-blind trial of house-dust mite immunotherapy in asthmatic children resident at high altitude

1 reference

12 December 2020

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

1 reference

12 December 2020

European allergen extract units and potency: review of available information.

1 reference

12 December 2020

Sublingual immunotherapy: a comprehensive review.

1 reference

12 December 2020

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

12 December 2020

Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy

1 reference

12 December 2020

Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review

1 reference

12 December 2020

Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan

1 reference

12 December 2020

A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients

1 reference

12 December 2020

Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

1 reference

12 December 2020

Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children

1 reference

12 December 2020

The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification

1 reference

12 December 2020

Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children

1 reference

12 December 2020

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

1 reference

12 December 2020

Anaphylaxis to multiple pollen allergen sublingual immunotherapy

1 reference

12 December 2020

Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children

1 reference

12 December 2020

Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration

1 reference

12 December 2020

Shorter dosing intervals of sublingual immunotherapy lead to more efficacious treatment in a mouse model of allergic inflammation

1 reference

12 December 2020

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

[Sublingual immunotherapy in children with asthma or rhinoconjunctivitis: not enough evidence because of poor quality of the studies; a systematic review of literature]

1 reference

12 December 2020

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

1 reference

12 December 2020

The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis

1 reference

12 December 2020

Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite

1 reference

12 December 2020

Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children

1 reference

12 December 2020

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

12 December 2020

The value of hyposensitization therapy for bronchial asthma in children--a 14-year study

1 reference

12 December 2020

The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus

1 reference

12 December 2020

Induced apoptosis of TH2 lymphocytes in asthmatic children treated with Dermatophagoides pteronyssinus immunotherapy

1 reference

12 December 2020

Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house-dust mite or to both house-dust mite and grass pollen

1 reference

12 December 2020

Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study

1 reference

12 December 2020

Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose

1 reference

12 December 2020

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children

1 reference

12 December 2020

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

1 reference

12 December 2020

Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study

1 reference

12 December 2020

Double‐blind placebo‐controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children

1 reference

12 December 2020

Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.

1 reference

12 December 2020

Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood

1 reference

12 December 2020

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

12 December 2020

Does specific immunotherapy injection cause an increase in bronchial reactivity?

1 reference

12 December 2020

Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy

1 reference

12 December 2020

Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa

1 reference

12 December 2020

Sublingual immunotherapy in the treatment of children

1 reference

12 December 2020

Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.

1 reference

12 December 2020

10.1007/S11882-008-0087-6

Identifiers

DOI

1 reference

19 August 2017

1 reference